Literature DB >> 20102279

Attributable costs of surgical site infection and endometritis after low transverse cesarean delivery.

Margaret A Olsen1, Anne M Butler, Denise M Willers, Gilad A Gross, Barton H Hamilton, Victoria J Fraser.   

Abstract

BACKGROUND: Accurate data on costs attributable to hospital-acquired infections are needed to determine their economic impact and the cost-benefit of potential preventive strategies.
OBJECTIVE: To determine the attributable costs of surgical site infection (SSI) and endometritis (EMM) after cesarean section by means of 2 different methods.
DESIGN: Retrospective cohort.
SETTING: Barnes-Jewish Hospital, a 1,250-bed academic tertiary care hospital. PATIENTS: There were 1,605 women who underwent low transverse cesarean section from July 1999 through June 2001.
METHODS: Attributable costs of SSI and EMM were determined by generalized least squares (GLS) and propensity score matched-pairs by means of administrative claims data to define underlying comorbidities and procedures. For the matched-pairs analyses, uninfected control patients were matched to patients with SSI or with EMM on the basis of their propensity to develop infection, and the median difference in costs was calculated.
RESULTS: The attributable total hospital cost of SSI calculated by GLS was $3,529 and by propensity score matched-pairs was $2,852. The attributable total hospital cost of EMM calculated by GLS was $3,956 and by propensity score matched-pairs was $3,842. The majority of excess costs were associated with room and board and pharmacy costs.
CONCLUSIONS: The costs of SSI and EMM were lower than SSI costs reported after more extensive operations. The attributable costs of EMM calculated by the 2 methods were very similar, whereas the costs of SSI calculated by propensity score matched-pairs were lower than the costs calculated by GLS. The difference in costs determined by the 2 methods needs to be considered by investigators who are performing cost analyses of hospital-acquired infections.

Entities:  

Mesh:

Year:  2010        PMID: 20102279      PMCID: PMC3626096          DOI: 10.1086/650755

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  26 in total

1.  The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs.

Authors:  K B Kirkland; J P Briggs; S L Trivette; W E Wilkinson; D J Sexton
Journal:  Infect Control Hosp Epidemiol       Date:  1999-11       Impact factor: 3.254

2.  An economic analysis of surgical wound infection.

Authors:  J Reilly; S Twaddle; J McIntosh; L Kean
Journal:  J Hosp Infect       Date:  2001-12       Impact factor: 3.926

3.  The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed.

Authors:  R Plowman; N Graves; M A Griffin; J A Roberts; A V Swan; B Cookson; L Taylor
Journal:  J Hosp Infect       Date:  2001-03       Impact factor: 3.926

4.  Reducing the incidence of infection after caesarean section: implications of prophylaxis with antibiotics for hospital resources.

Authors:  M Mugford; J Kingston; I Chalmers
Journal:  BMJ       Date:  1989-10-21

5.  The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost.

Authors:  James D Whitehouse; N Deborah Friedman; Kathryn B Kirkland; William J Richardson; Daniel J Sexton
Journal:  Infect Control Hosp Epidemiol       Date:  2002-04       Impact factor: 3.254

6.  Nonrandom selection and the attributable cost of surgical-site infections.

Authors:  Christopher S Hollenbeak; Denise Murphy; William C Dunagan; Victoria J Fraser
Journal:  Infect Control Hosp Epidemiol       Date:  2002-04       Impact factor: 3.254

7.  Cost of surgical site infections following coronary artery bypass surgery.

Authors:  A W Jenney; G A Harrington; P L Russo; D W Spelman
Journal:  ANZ J Surg       Date:  2001-11       Impact factor: 1.872

8.  Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost.

Authors:  Sarah A McGarry; John J Engemann; Kenneth Schmader; Daniel J Sexton; Keith S Kaye
Journal:  Infect Control Hosp Epidemiol       Date:  2004-06       Impact factor: 3.254

9.  Electronic surveillance of antibiotic exposure and coded discharge diagnoses as indicators of postoperative infection and other quality assurance measures.

Authors:  L R Hirschhorn; J S Currier; R Platt
Journal:  Infect Control Hosp Epidemiol       Date:  1993-01       Impact factor: 3.254

10.  Health and economic impact of surgical site infections diagnosed after hospital discharge.

Authors:  Eli N Perencevich; Kenneth E Sands; Sara E Cosgrove; Edward Guadagnoli; Ellen Meara; Richard Platt
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

View more
  17 in total

1.  Infectious morbidity is higher after second-stage compared with first-stage cesareans.

Authors:  Methodius G Tuuli; Lucy Liu; Ryan E Longman; Anthony O Odibo; George A Macones; Alison G Cahill
Journal:  Am J Obstet Gynecol       Date:  2014-03-18       Impact factor: 8.661

2.  Prophylactic Wound Vacuum Therapy after Cesarean Section to Prevent Wound Complications in the Obese Population: A Randomized Controlled Trial (the ProVac Study).

Authors:  Kelly Ruhstaller; Katheryne L Downes; Suchitra Chandrasekaran; Sindhu Srinivas; Celeste Durnwald
Journal:  Am J Perinatol       Date:  2017-07-13       Impact factor: 1.862

3.  A journey to zero: reduction of post-operative cesarean surgical site infections over a five-year period.

Authors:  Evelyn Hickson; Jeanette Harris; David Brett
Journal:  Surg Infect (Larchmt)       Date:  2015-03-31       Impact factor: 2.150

4.  Economic Evaluation of Adjunctive Azithromycin Prophylaxis for Cesarean Delivery.

Authors:  Lorie M Harper; Meredith Kilgore; Jeff M Szychowski; William W Andrews; Alan T N Tita
Journal:  Obstet Gynecol       Date:  2017-08       Impact factor: 7.661

5.  Comparison of costs of surgical site infection and endometritis after cesarean delivery using claims and medical record data.

Authors:  Margaret A Olsen; Anne M Butler; Denise M Willers; Gilad A Gross; Victoria J Fraser
Journal:  Infect Control Hosp Epidemiol       Date:  2010-08       Impact factor: 3.254

6.  Impact of evidence-based interventions on wound complications after cesarean delivery.

Authors:  Lorene A Temming; Nandini Raghuraman; Ebony B Carter; Molly J Stout; Roxane M Rampersad; George A Macones; Alison G Cahill; Methodius G Tuuli
Journal:  Am J Obstet Gynecol       Date:  2017-06-08       Impact factor: 8.661

7.  Trends in mortality, length of stay, and hospital charges associated with health care-associated infections, 2006-2012.

Authors:  Sherry Glied; Bevin Cohen; Jianfang Liu; Matthew Neidell; Elaine Larson
Journal:  Am J Infect Control       Date:  2016-05-17       Impact factor: 2.918

8.  A Randomized Trial Comparing Skin Antiseptic Agents at Cesarean Delivery.

Authors:  Methodius G Tuuli; Jingxia Liu; Molly J Stout; Shannon Martin; Alison G Cahill; Anthony O Odibo; Graham A Colditz; George A Macones
Journal:  N Engl J Med       Date:  2016-02-04       Impact factor: 91.245

9.  Use of Quantile Regression to Determine the Impact on Total Health Care Costs of Surgical Site Infections Following Common Ambulatory Procedures.

Authors:  Margaret A Olsen; Fang Tian; Anna E Wallace; Katelin B Nickel; David K Warren; Victoria J Fraser; Nandini Selvam; Barton H Hamilton
Journal:  Ann Surg       Date:  2017-02       Impact factor: 12.969

10.  Effect of Prophylactic Negative Pressure Wound Therapy vs Standard Wound Dressing on Surgical-Site Infection in Obese Women After Cesarean Delivery: A Randomized Clinical Trial.

Authors:  Methodius G Tuuli; Jingxia Liu; Alan T N Tita; Sherri Longo; Amanda Trudell; Ebony B Carter; Anthony Shanks; Candice Woolfolk; Aaron B Caughey; David K Warren; Anthony O Odibo; Graham Colditz; George A Macones; Lorie Harper
Journal:  JAMA       Date:  2020-09-22       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.